DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Starter-dose teaser

An advertised price that applies only at the bottom of the titration ladder — the lowest such figure in this index is $133 — with no published maintenance price behind it. Unrankable by definition, and the reason every figure on this site is quoted at the maintenance basis instead.

Released · Last reviewed · how we verify

Where the term bites in the current data: our dated tirzepatide reads run $129–$399/month all-in and semaglutide $99–$299 (newest reads; NexLife November 20, 2026), and nearly every dollar of those spreads is explained by the vocabulary on this glossary’s pages — memberships inside or outside headline figures, flat versus tiered ladders, prepaid terms dressed as monthly prices, evidence flags separating captures from claims. Reading this market is mostly a matter of knowing which of those words applies to the number in front of you.

The index’s live example: an advertised $133 with no maintenance figure behind it, recorded and excluded from every ranking for exactly this reason. Related figures live on the pages this term links to, and every one of them regenerates from the same dataset this definition does.

See the term in action across the price database and the methodology.

All-in priceMaintenance-dose basisDose-flat pricingDose-tiered pricingMembership feePrepaid term

Primary sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.